Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter Trial

Gregory A. Wiseman, Karel Pacak, Mary S. O'Dorisio, Donald R. Neumann, Alan D. Waxman, David A. Mankoff, Sherif I. Heiba, Aldo N. Serafini, Sabah S. Tumeh, Natalie Khutoryansky and Arnold F. Jacobson
Journal of Nuclear Medicine September 2009, 50 (9) 1448-1454; DOI: https://doi.org/10.2967/jnumed.108.058701
Gregory A. Wiseman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karel Pacak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary S. O'Dorisio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald R. Neumann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan D. Waxman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Mankoff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherif I. Heiba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aldo N. Serafini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabah S. Tumeh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Khutoryansky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnold F. Jacobson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Figures
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 50 (9)
Journal of Nuclear Medicine
Vol. 50, Issue 9
September 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter Trial
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter Trial
Gregory A. Wiseman, Karel Pacak, Mary S. O'Dorisio, Donald R. Neumann, Alan D. Waxman, David A. Mankoff, Sherif I. Heiba, Aldo N. Serafini, Sabah S. Tumeh, Natalie Khutoryansky, Arnold F. Jacobson
Journal of Nuclear Medicine Sep 2009, 50 (9) 1448-1454; DOI: 10.2967/jnumed.108.058701

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter Trial
Gregory A. Wiseman, Karel Pacak, Mary S. O'Dorisio, Donald R. Neumann, Alan D. Waxman, David A. Mankoff, Sherif I. Heiba, Aldo N. Serafini, Sabah S. Tumeh, Natalie Khutoryansky, Arnold F. Jacobson
Journal of Nuclear Medicine Sep 2009, 50 (9) 1448-1454; DOI: 10.2967/jnumed.108.058701
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Tumor Dose-Response Relationship of [131I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [124I]MIBG PET
  • Long-term disease-free survival after MIBG therapy for metastatic pheochromocytoma
  • Clinical Applications and the Roles of Transporters in Disposition, Tumor Targeting, and Tissue Toxicity of meta-Iodobenzylguanidine
  • Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
  • Imaging of Pheochromocytoma and Paraganglioma
  • Norepinephrine Transporter as a Target for Imaging and Therapy
  • Phaeochromocytoma presenting as an acute coronary syndrome
  • Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1
  • Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters
  • MANAGEMENT OF ENDOCRINE DISEASE: Clinical management of paragangliomas
  • False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease
  • Survey of the Performance of Commercial Dose Calibrators for Measurement of 123I Activity
  • Pheochromocytomas detected by biochemical screening in predisposed subjects are associated with lower prevalence of clinical and biochemical manifestations and smaller tumors than pheochromocytomas detected by signs and symptoms
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire